Physician profile
Hila Refael
NPI 1750934824
$3,395.93
in general payments reported to CMS, 2019-2025
12 companies · $60.48 in 2025
The $60.48 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $575 · 2022: $576 · 2023: $598 · 2024: $1,586 · 2025: $60.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680 · Travel and Lodging: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.98 |
| Travel and Lodging | $565.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,454.31 | 2024 | |
| Janssen Pharmaceuticals, INC | $379.47 | 2021-2022 | |
| Abbvie INC. | $331.20 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $319.51 | 2022-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $262.52 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.06 | 2021-2022 | |
| Csl Behring | $121.29 | 2023-2024 | Kcentra |
| Baxter Healthcare | $100.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.73 | 2022-2023 | Jardiance |
| Daiichi Sankyo INC. | $80.78 | 2023-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $22.18 | 2023 | Verquvo |
| Pfizer INC. | $12.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hila Refael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.